P-174 OPTIMISE: Optimization of treatment selection and follow-up in oligometastatic colorectal cancer – a ctDNA-guided phase II randomized approach with a run-in feasibility part

Autor: K. Spindler, L. Callesen, R. Andersen, N. Pallisgaard, S. Kramer, S. Schlander, S. Rafaelsen, A. Boysen, L. Jensen, A. Jakobsen, T. Hansen

Publikováno v: Annals of Oncology. 33:S311-S312

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::dab8d834ecfc0bbb123f2d680b3be476
https://doi.org/10.1016/j.annonc.2022.04.264

Methodological development and biological observations of cell free DNA with a simple direct fluorescent assay in colorectal cancer

Autor: A.K. Boysen, B.S. Sørensen, A.C. Lefevre, R. Abrantes, J.S. Johansen, B.V. Jensen, J.V. Schou, F.O. Larsen, D. Nielsen, H. Taflin, B. Gustavson, Y. Wettergren, B.S. Sorensen, A.H. Ree, S. Dueland, N. Pallisgaard, K.L. Spindler

Publikováno v: Boysen, A K, Sorensen, B S, Lefevre, A C, Abrantes, R, Johansen, J S, Jensen, B V, Schou, J V, Larsen, F O, Nielsen, D, Taflin, H, Gustavson, B, Wettergren, Y, Sorensen, B S, Ree, A H, Dueland, S, Pallisgaard, N & Spindler, K L 2018, ' Methodological development and biological observations of cell free DNA with a simple direct fluorescent assay in colorectal cancer ', Clinica chimica acta; international journal of clinical chemistry, vol. 487, pp. 107-111 . https://doi.org/10.1016/j.cca.2018.09.029

BACKGROUND: Cell free DNA (cfDNA) has shown promising utility as prognostic biomarker for patients with colorectal cancer (CRC), with an ongoing need to optimize and validate the laboratory methodology. Here, we report our optimization and validation

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::58098b1c364220ffb5edb0d41f36eaa0
https://doi.org/10.1016/j.cca.2018.09.029

OC-0619 Plasma HPV elimination patterns as strong predictor of outcome in primary Anal Cancer treatment

Autor: C. Kronborg, K.L. Wind, Karen-Lise Garm Spindler, N. Pallisgaard, S.N. Krag, A.C. Lefèvre

Publikováno v: Radiotherapy and Oncology. 161:S483

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::40b3686f33278f2dab5a9689c3857663
https://doi.org/10.1016/s0167-8140(21)06975-9

Total circulating cell-free DNA (cfDNA) as a prognostic biomarker in metastatic colorectal cancer prior to first-line oxaliplatin-based chemotherapy

Autor: J. Hamfjord, T. Guren, O. Dajani, B. Glimelius, H. Sorbye, P. Pfeiffer, T. Christoffersen, O. Lingjærde, K. Tveit, E. Kure, N. Pallisgaard, K. Spindler

Publikováno v: Hamfjord, J, Guren, T, Dajani, O, Glimelius, B, Sorbye, H, Pfeiffer, P, Christoffersen, T, Lingjaerde, O, Tveit, K, Kure, E, Pallisgaard, N & Spindler, K 2018, ' Total circulating cell-free DNA (cfDNA) as a prognostic biomarker in metastatic colorectal cancer prior to first-line oxaliplatin-based chemotherapy ', Annals of Oncology, vol. 29, no. Suppl. 5, pp. v109 . https://doi.org/10.1093/annonc/mdy149.025

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6031f5584381b60888f38fabcd2a9760
https://portal.findresearcher.sdu.dk/da/publications/0672dd55-bbf8-4a2f-be66-ab554bf39bec

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.